Menu

Blog

Aug 17, 2023

This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions

Posted by in categories: biotech/medical, genetics

Benjamin Oakes’ Scribe Therapeutics is developing specialized Crispr proteins to tackle a wide range of diseases–and it’s garnered deals with Big Pharma potentially worth over $4 billion.

Comments are closed.